Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandi Freeman

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Plos One|July 29, 2021
Comparison of the SARS-CoV-2 spike protein ELISA and the Abbott Architect SARS-CoV-2 IgG nucleocapsid protein assays for detection of antibodiesAshutosh Wadhwa, Sherry Yin, Brandi Freeman, et al.
The Lancet. Child & Adolescent Health|September 29, 2023
Paediatric acute hepatitis of unknown aetiology: a national surveillance investigation in the USA during 2021 and 2022Jordan Cates, Julia M Baker, Olivia Almendares, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillanceBrandi Freeman, Sandra Lester, Lisa Mills, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2020
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, TennesseeWilliam B Stubblefield, H Keipp Talbot, Leora R Feldstein, et al.
Plos One|October 27, 2022
Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020‒April 2021Farrell A Tobolowsky, Michelle A Waltenburg, Erin D Moritz, et al.
MMWR. Morbidity and Mortality Weekly Report|March 25, 2021
Low SARS-CoV-2 Transmission in Elementary Schools - Salt Lake County, Utah, December 3, 2020-January 31, 2021Rebecca B Hershow, Karen Wu, Nathaniel M Lewis, et al.
Annals of Internal Medicine|April 26, 2021
Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home OutbreakSusannah L McKay, Farrell A Tobolowsky, Erin D Moritz, et al.
Emerging Infectious Diseases|May 30, 2020
Investigation and Serologic Follow-Up of Contacts of an Early Confirmed Case-Patient with COVID-19, Washington, USAVictoria T Chu, Brandi Freeman-Ponder, Scott Lindquist, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2020
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020Sridhar V Basavaraju, Monica E Patton, Kacie Grimm, et al.
JAMA Internal Medicine|July 22, 2020
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020Fiona P Havers, Carrie Reed, Travis Lim, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Plos One|July 29, 2021
Comparison of the SARS-CoV-2 spike protein ELISA and the Abbott Architect SARS-CoV-2 IgG nucleocapsid protein assays for detection of antibodiesAshutosh Wadhwa, Sherry Yin, Brandi Freeman, et al.
The Lancet. Child & Adolescent Health|September 29, 2023
Paediatric acute hepatitis of unknown aetiology: a national surveillance investigation in the USA during 2021 and 2022Jordan Cates, Julia M Baker, Olivia Almendares, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillanceBrandi Freeman, Sandra Lester, Lisa Mills, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 7, 2020
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, TennesseeWilliam B Stubblefield, H Keipp Talbot, Leora R Feldstein, et al.
Plos One|October 27, 2022
Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020‒April 2021Farrell A Tobolowsky, Michelle A Waltenburg, Erin D Moritz, et al.
MMWR. Morbidity and Mortality Weekly Report|March 25, 2021
Low SARS-CoV-2 Transmission in Elementary Schools - Salt Lake County, Utah, December 3, 2020-January 31, 2021Rebecca B Hershow, Karen Wu, Nathaniel M Lewis, et al.
Annals of Internal Medicine|April 26, 2021
Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home OutbreakSusannah L McKay, Farrell A Tobolowsky, Erin D Moritz, et al.
Emerging Infectious Diseases|May 30, 2020
Investigation and Serologic Follow-Up of Contacts of an Early Confirmed Case-Patient with COVID-19, Washington, USAVictoria T Chu, Brandi Freeman-Ponder, Scott Lindquist, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2020
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020Sridhar V Basavaraju, Monica E Patton, Kacie Grimm, et al.
JAMA Internal Medicine|July 22, 2020
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020Fiona P Havers, Carrie Reed, Travis Lim, et al.
Pageof 3